Sumitomo Mitsui DS Asset Management Company Ltd Buys 3,675 Shares of Danaher Corporation $DHR

Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in Danaher Corporation (NYSE:DHR) by 4.0% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 94,949 shares of the conglomerate’s stock after buying an additional 3,675 shares during the quarter. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Danaher were worth $21,036,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of DHR. Marquette Asset Management LLC raised its stake in shares of Danaher by 192.1% in the 3rd quarter. Marquette Asset Management LLC now owns 111 shares of the conglomerate’s stock valued at $25,000 after acquiring an additional 73 shares during the period. N.E.W. Advisory Services LLC acquired a new stake in Danaher in the 2nd quarter valued at approximately $25,000. Main Street Group LTD acquired a new stake in Danaher in the 1st quarter valued at approximately $25,000. Field & Main Bank purchased a new stake in Danaher in the second quarter valued at approximately $29,000. Finally, Evolution Wealth Management Inc. lifted its stake in Danaher by 208.0% during the first quarter. Evolution Wealth Management Inc. now owns 154 shares of the conglomerate’s stock worth $29,000 after purchasing an additional 104 shares in the last quarter. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Danaher Stock Performance

NYSE:DHR opened at $224.78 on Wednesday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a fifty day simple moving average of $214.70 and a two-hundred day simple moving average of $196.54. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a market cap of $158.02 billion, a price-to-earnings ratio of 39.93, a price-to-earnings-growth ratio of 2.82 and a beta of 0.76.

Danaher (NYSE:DHR) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.85 by $0.09. The business had revenue of $6.26 billion for the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same period last year, the firm earned $0.77 earnings per share. As a group, equities analysts anticipate that Danaher Corporation will post 8.53 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Shareholders of record on Wednesday, September 30th will be issued a dividend of $0.40 per share. The ex-dividend date is Wednesday, September 30th. This represents a $1.60 annualized dividend and a yield of 0.7%. Danaher’s dividend payout ratio is 28.42%.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Wells Fargo & Company lowered their price target on Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. Royal Bank Of Canada boosted their price objective on Danaher from $215.00 to $250.00 and gave the company an “outperform” rating in a report on Monday, October 5th. UBS Group assumed coverage on Danaher in a research note on Wednesday, September 9th. They set a “buy” rating and a $250.00 target price on the stock. Barclays raised their target price on Danaher from $230.00 to $255.00 and gave the company an “overweight” rating in a report on Wednesday, October 7th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 target price on shares of Danaher in a research report on Wednesday, July 22nd. Two analysts have rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and four have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and a consensus price target of $235.41.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that develops products, services and solutions for the life sciences, biotechnology and diagnostics markets. Its offerings help researchers, pharmaceutical and biotechnology companies, healthcare providers and other organizations conduct scientific research, develop and manufacture medicines, and diagnose disease.

The company operates through businesses that provide bioprocessing equipment and technologies, laboratory instruments, consumables, analytical tools and clinical diagnostic systems.